Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS value-based purchasing

This article was originally published in The Gray Sheet

Executive Summary

CMS report to Congress on value-based purchasing, released Nov. 26, suggests setting aside 2%-5% of hospital inpatient payments to use as a financial incentive to reward hospitals that meet or show substantial improvement for 20 quality measures. Congress asked the agency to come up with the plan in time to implement changes for fiscal year 2009 (1"The Gray Sheet" April 30, 2007, p. 12). The report outlines a three-year phase-in, building upon current pay-for-reporting requirements. Proposed measures relate to process-of-care, outcomes and patient satisfaction for treatment of heart attack, heart failure, pneumonia and surgical infection prevention. Industry says it will closely watch how Congress acts on the report to ensure that any future incentive-based program does not interfere with patient access to care

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025543

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel